semaglutide and type 1 diabetes Effectiveness Safety of in Diabetes: A Danish Nationwide Cohort Study (2018–2024) Increase in people using weight

Sure, there are weight loss success stories, but behind the scenes people are navigating insurance challenges, side effects, and the possibility of taking GLP-1 medications for life

Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)

Compounded tirzepatide with B12 is pink

Call us at 1-844-353-3734

Matthias H

It is always advisable to follow the recommended dosage and consult a healthcare professional if you are pregnant, nursing, or have a medical condition